RecruitingNot ApplicableNCT05564949

A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases

A "Classic" Ketogenic Diet as a Complementary Therapeutic Management on Patients With High-grade Gliomas and Brain Metastases.


Sponsor

Attikon Hospital

Enrollment

15 participants

Start Date

Sep 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a ketogenic diet (a high-fat, very low-carbohydrate eating plan) can complement standard treatment for people with high-grade brain tumors — specifically glioblastoma (grade 4) or brain metastases. The idea is that cancer cells are heavily reliant on sugar for energy, and severely cutting carbohydrates may slow their growth. **You may be eligible if...** - You are between 18 and 80 years old - You have been newly diagnosed with glioblastoma grade 4, OR your brain tumor has recurred after surgery, radiation, and chemotherapy - You have normal liver and kidney function - Your performance status (Karnofsky Score) is 50 or above (able to care for most of your own needs) - You can give informed consent **You may NOT be eligible if...** - You have diabetes mellitus - Your life expectancy is more than 3 months (note: this is an unusual exclusion — confirm with your doctor) - You are unable to follow a strict dietary regimen - You had your gallbladder removed within the past year - You have a genetic disorder of fat metabolism Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCKD

Patients/families will meet with the study dietician to discuss the CKD, ask questions, and plan clinic visits. Training will take place about diet, meal planning, and ketones/glucose monitoring. The dietitian will follow the patient throughout treatment. Patients will measure their urine ketosis with urine test strips and capillary ketones with blood ketone meters daily, and they will complete records from the start till the end of the study. Finally, they will meet with the dietitian at follow-up visits and on an as-needed basis.


Locations(2)

Arezina Kasti

Chaïdári, Athens, Greece

Attikon University General Hospital

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05564949


Related Trials